Related content

Efficacy and safety of treatment with incobotulinum toxin A (botulinum neurotoxin type A free from complexing proteins; NT 201) in post-stroke upper limb spasticity

By Kaňovský Petr   Slawek Jaroslaw   Denes Zoltan   Platz Thomas   Comes Georg   Grafe Susanne   Pulte Irena  

Journal of Rehabilitation Medicine, Vol. 43, Iss. 6, 2011-05 ,pp. : 486-492

Medical Journals Limited

Access to resources Recommend Favorite

Cost-effectiveness of botulinum toxin type a in the treatment of post-stroke spasticity

By Ward Anthony   Roberts Graeme   Warner Juliet   Gillard Samantha  

Journal of Rehabilitation Medicine, Vol. 37, Iss. 4, 2005-07 ,pp. : 252-257

Medical Journals Limited

Access to resources Recommend Favorite

Assessing the neurophysiological effects of botulinum toxin treatment for adults with focal limb spasticity: a systematic review

By Phadke Chetan P.   Ismail Farooq   Boulias Chris  

Disability and Rehabilitation, Vol. 34, Iss. 2, 2012-01 ,pp. : 91-100

Informa Healthcare

Access to resources Recommend Favorite

Goal Attainment Scaling in the Evaluation of Treatment of Upper Limb Spasticity with Botulinum Toxin: A Secondary Analysis from a Double-blind Placebo-Controlled Randomized Clinical Trial

By Turner-Stokes Lynne   Baguley Ian J.   De Graaff Stephen   Katrak Pesi   Davies Leo   McCrory Paul   Hughes Andrew  

Journal of Rehabilitation Medicine, Vol. 42, Iss. 1, 2010-01 ,pp. : 81-89

Medical Journals Limited

Access to resources Recommend Favorite

Comparative trial of a novel botulinum neurotoxin type A versus onabotulinumtoxinA in the treatment of glabellar lines: A multicenter, randomized, double‐blind, active‐controlled study

By  

INTERNATIONAL JOURNAL OF DERMATOLOGY, Vol. 54, Iss. 2, 2015-02 ,pp. : 227-234

John Wiley & Sons Inc

Access to resources Recommend Favorite